173 related articles for article (PubMed ID: 21400531)
1. Metabolomics and surgical oncology: Potential role for small molecule biomarkers.
Davis VW; Bathe OF; Schiller DE; Slupsky CM; Sawyer MB
J Surg Oncol; 2011 Apr; 103(5):451-9. PubMed ID: 21400531
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in metabolomics in oncology.
O'Connell TM
Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics and detection of colorectal cancer in humans: a systematic review.
Wang H; Tso VK; Slupsky CM; Fedorak RN
Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
[TBL] [Abstract][Full Text] [Related]
6. Metabonomics: a useful tool for the future surgeon.
Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics in cancer: a bench-to-bedside intersection.
Claudino WM; Goncalves PH; di Leo A; Philip PA; Sarkar FH
Crit Rev Oncol Hematol; 2012 Oct; 84(1):1-7. PubMed ID: 22429650
[TBL] [Abstract][Full Text] [Related]
8. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics in paediatric oncology: a potential still to be exploited.
Spiga L; Atzori L; Noto A; Moretti C; Mussap M; Masile A; Lussu M; Fanos V
J Matern Fetal Neonatal Med; 2013 Oct; 26 Suppl 2():20-3. PubMed ID: 24059547
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive biomarkers for detection and staging of colorectal cancer.
Booth RA
Cancer Lett; 2007 Apr; 249(1):87-96. PubMed ID: 17275174
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling of pteridines for determination of potential biomarkers in cancer diseases.
Kośliński P; Bujak R; Daghir E; Markuszewski MJ
Electrophoresis; 2011 Aug; 32(15):2044-54. PubMed ID: 21563184
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.
Nugent M; Miller N; Kerin MJ
Eur J Surg Oncol; 2011 Aug; 37(8):649-54. PubMed ID: 21632200
[TBL] [Abstract][Full Text] [Related]
13. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics in cancer biomarker discovery: current trends and future perspectives.
Armitage EG; Barbas C
J Pharm Biomed Anal; 2014 Jan; 87():1-11. PubMed ID: 24091079
[TBL] [Abstract][Full Text] [Related]
15. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y; Xie G; Jia W
J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
[TBL] [Abstract][Full Text] [Related]
16. [Omics docking and molecular classification in colorectal cancer].
Peng Y; Shen S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745
[TBL] [Abstract][Full Text] [Related]
17. Proteomic methodologies and their application in colorectal cancer research.
Ikonomou G; Samiotaki M; Panayotou G
Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.
Bathen TF; Sitter B; Sjøbakk TE; Tessem MB; Gribbestad IS
Cancer Res; 2010 Sep; 70(17):6692-6. PubMed ID: 20699363
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs are novel biomarkers of colorectal cancer.
Aslam MI; Taylor K; Pringle JH; Jameson JS
Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
[TBL] [Abstract][Full Text] [Related]
20. The discovery and validation of colorectal cancer biomarkers.
Ang CS; Phung J; Nice EC
Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
